Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75,482,273
-
Total 13F shares
-
1,295,959
-
Share change
-
-4,723
-
Total reported value
-
$2,917,000
-
Price per share
-
$2.25
-
Number of holders
-
9
-
Value change
-
-$7,988
-
Number of buys
-
2
-
Number of sells
-
5
Institutional Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q4 2019
As of 31 Dec 2019,
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,295,959 shares.
The largest 9 holders included
BOXER CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, SPHERA FUNDS MANAGEMENT LTD., Game Plan Financial Advisors, LLC, VANGUARD GROUP INC, MORGAN STANLEY, PNC Financial Services Group, Inc., LADENBURG THALMANN FINANCIAL SERVICES INC., and US BANCORP \DE\.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.